Else Nutrition Holdings Beheer

Beheer criteriumcontroles 4/4

De CEO Else Nutrition Holdings is Hamutal Yitzhak, benoemd in Jun2019, heeft een ambtstermijn van 5.42 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 293.14K, bestaande uit 87.4% salaris en 12.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 7.36% van de aandelen van het bedrijf, ter waarde CA$ 330.75K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.4 jaar en 5 jaar.

Belangrijke informatie

Hamutal Yitzhak

Algemeen directeur

CA$293.1k

Totale compensatie

Percentage CEO-salaris	87.4%
Dienstverband CEO	5.4yrs
Eigendom CEO	7.4%
Management gemiddelde ambtstermijn	5.4yrs
Gemiddelde ambtstermijn bestuur	5yrs

Recente managementupdates

Recent updates

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Apr 06

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Aug 15

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Dec 20

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Aug 23

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Jan 28

Here's Why We're Watching Else Nutrition Holdings' (CVE:BABY) Cash Burn Situation

Oct 20

We Think Else Nutrition Holdings (CVE:BABY) Can Afford To Drive Business Growth

Jul 13

Analyse CEO-vergoeding

Hoe is Hamutal Yitzhak's beloning veranderd ten opzichte van Else Nutrition Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-CA$16m
Jun 30 2024	n/a	n/a	-CA$12m
Mar 31 2024	n/a	n/a	-CA$13m
Dec 31 2023	CA$293k	CA$256k	-CA$16m
Sep 30 2023	n/a	n/a	-CA$16m
Jun 30 2023	n/a	n/a	-CA$21m
Mar 31 2023	n/a	n/a	-CA$18m
Dec 31 2022	CA$355k	CA$274k	-CA$18m
Sep 30 2022	n/a	n/a	-CA$10m
Jun 30 2022	n/a	n/a	-CA$8m
Mar 31 2022	n/a	n/a	-CA$11m
Dec 31 2021	CA$341k	CA$275k	-CA$2m
Sep 30 2021	n/a	n/a	-CA$18m
Jun 30 2021	n/a	n/a	-CA$21m
Mar 31 2021	n/a	n/a	-CA$20m
Dec 31 2020	CA$307k	CA$254k	-CA$24m
Sep 30 2020	n/a	n/a	-CA$11m
Jun 30 2020	n/a	n/a	-CA$9m
Mar 31 2020	n/a	n/a	-CA$7m
Dec 31 2019	CA$261k	CA$129k	-CA$5m

Compensatie versus markt: De totale vergoeding ($USD 209.67K ) Hamutal } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 169.37K ).

Compensatie versus inkomsten: De vergoeding van Hamutal is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Hamutal Yitzhak (55 yo)

5.4yrs

Tenure

CA$293,136

Compensatie

Ms. Hamutal Yitzhak serves as Chief Executive Officer and Chairman of the Board at Else Nutrition Holdings Inc since June 12, 2019 and has been its Director since June 12, 2019. She is Co-Founder of Else N...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Hamutal Yitzhak	Co-Founder	5.4yrs	CA$293.14k	7.36% CA$ 330.8k
Uriel Kesler	Co-Founder	5.4yrs	CA$293.14k	7.36% CA$ 330.8k
Shay Shamir	CFO & Corporate Secretary	5.4yrs	CA$194.91k	geen gegevens
Avi Markus	Senior Vice President of North America Retail	no data	CA$303.03k	geen gegevens
Marc Kenigsberg	CMO	no data	CA$324.65k	geen gegevens
Michael Azar	Co-Founder & CTO	5.4yrs	CA$233.34k	1.64% CA$ 73.5k
Reuben Halevi	Vice President of Sales Operations	5.4yrs	CA$220.68k	0.23% CA$ 10.1k
Liliana Frimerman	Head of Bookkeeping & Payroll	no data	geen gegevens	geen gegevens

5.4yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BABY is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Hamutal Yitzhak	Co-Founder	5.4yrs	CA$293.14k	7.36% CA$ 330.8k
Uriel Kesler	Co-Founder	5.4yrs	CA$293.14k	7.36% CA$ 330.8k
Sukvinder Puar	Non-Independent Director	9.6yrs	CA$120.00k	0.031% CA$ 1.4k
Eli Ronen	Independent Director	5yrs	geen gegevens	geen gegevens
Bo Lonnerdal	Member of Scientific Advisory Board	2.8yrs	geen gegevens	geen gegevens
Satwinder Mann	Independent Director	5.4yrs	geen gegevens	0.36% CA$ 16.3k
Akash Bedi	Independent Director	4.7yrs	geen gegevens	geen gegevens
Jon Vanderhoof	Member of Advisory Board	5.1yrs	geen gegevens	geen gegevens
Raanan Shamir	Member of Advisory Board	no data	geen gegevens	geen gegevens
Ron Shaoul	Member of Advisory Board	no data	geen gegevens	geen gegevens
Hania Szajewska	Member of Scientific Advisory Board	3.6yrs	geen gegevens	geen gegevens
Carina Venter	Member of Scientific Advisory Board	3.6yrs	geen gegevens	geen gegevens

5.0yrs

Gemiddelde duur

57.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BABY wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).

Else Nutrition Holdings Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Else Nutrition Holdings Inc., Annual General Meeting, Jun 12, 2024

Else Nutrition Holdings Inc. Appoints Yaki Lutski to the Board of Directors

High number of new directors

Vice President of Sales Operations recently sold CA$134k worth of stock

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: CA$0.016 loss per share (vs CA$0.009 profit in 3Q 2023)

New major risk - Shareholder dilution

New major risk - Market cap size

Second quarter 2024 earnings released: CA$0.017 loss per share (vs CA$0.032 loss in 2Q 2023)

New minor risk - Share price stability

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of $2 million.

Else Nutrition Holdings Inc. Completes Successful Product Rollout At 308 Locations of Leading Independent Grocery Chain

Else Nutrition Holdings Inc. Completes Rollout of Novel Ready-To-Drink Kids Shakes in 276 Stores of Major Midwest Retailer

Else Nutrition Holdings Inc. Adds New, Ready-To-Drink Kids Shakes At Canada's Largest Grocery Chain

First quarter 2024 earnings released: CA$0.039 loss per share (vs CA$0.07 loss in 1Q 2023)

Insufficient new directors

Else Nutrition Holdings Inc., Annual General Meeting, Jun 12, 2024

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Full year 2023 earnings released: CA$0.13 loss per share (vs CA$0.16 loss in FY 2022)

Else Nutrition Holdings Inc. Launches Ready-To-Drink Kids Shakes on One of Canada's Largest Online Retail Platform

Else Nutrition Holdings Inc. Launches Toddler and Kids Products in over 150 Stores of a Major Retail Chain Providing Potential Access to 2,000 US Stores

Else Announces Online Launch of Its Kids Ready-To-Drink Plant-Powered Shakes with One of Largest Retailers

ELSE NUTRITION HOLDINGS INC. Further Penetrates Canadian Market with Leading Retail Pharmacy Chain Listing of Ready-To-Drink Product

Else Nutrition Holdings Inc. Completes its First Large-Scale Production Run of its Ready-to-Drink Kids Shakes

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. Launches Full Product Range in the Canadian Retail Locations of One of the World's Largest Retailers of Organic and Natural Foods

Third quarter 2023 earnings released: EPS: CA$0.009 (vs CA$0.032 loss in 3Q 2022)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Else Nutrition Holdings Inc. to Report Q3, 2023 Results on Nov 14, 2023

Else Nutrition Holdings Inc. Announces the Launch of Its Highly Acclaimed, Plant-Based Complete Nutrition Toddler Drink in the United Kingdom

New minor risk - Share price stability

Else Nutrition Holdings Inc.'S Ready-To-Drink Kids Shakes Approved for Sale by Leading Online Marketplace

Else Nutrition Holdings Inc. Announces the Introduction of its First-Ever Ready-To-Drink (Rtd) Kids Nutritional Shakes

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.013 loss in 2Q 2022)

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Else Nutrition Holdings Inc. to Report Q2, 2023 Results on Aug 14, 2023

Else Nutrition Holdings Inc. Announces to Launch Its First-Ever Ready-To-Drink (RTD) Products in the Form of Kids Nutritional Shakes in Vanilla and Chocolate Flavors

Else Nutrition Holdings Inc. Achieves Another WIC Approval: Oklahoma Welcomes Kids Shakes and Toddler Nutrition Products

Else Nutrition Holdings Inc.'s Plant-Based Kids Shakes Now Approved by the Arizona Women, Infants, and Children Program

Else Nutrition Holdings Inc. Appoints Yaki Lutski to the Board of Directors

Else Nutrition Holdings Inc. Expands Baby, Toddler, and Kids Nutrition Choices Nationwide

First quarter 2023 earnings released: CA$0.07 loss per share (vs CA$0.069 loss in 1Q 2022)

Else Nutrition Holdings Inc. to Report Q1, 2023 Results on May 15, 2023

Else Nutrition Holdings Inc. Receives IRB Approval for Infant Growth Clinical Study Protocol

Else Nutrition Holdings Inc. announced that it expects to receive $13.75 million in funding from The Lind Partners, LLC

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Third quarter 2022 earnings released: CA$0.032 loss per share (vs CA$0.015 loss in 3Q 2021)

High number of new directors

Else Nutrition Holdings Inc. to Report Q3, 2022 Results on Nov 14, 2022

Else Nutrition Holdings Inc. Kids Products Launch At Retail

Price target increased to CA$4.50

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Second quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.05 loss in 2Q 2021)

Else Nutrition Holdings Inc. to Report Q2, 2022 Results on Aug 15, 2022

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 7.287 million.

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Vice President of Sales Operations recently sold CA$134k worth of stock

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

First quarter 2022 earnings released: CA$0.069 loss per share (vs CA$0.023 profit in 1Q 2021)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Provides Earnings Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Receives Approval for Its Novel Plant-Based Complete Nutrition for Toddlers & Kids to Be Listed At Lassens Natural Food & Vitamins Stores

Else Nutrition Holdings Inc. to Report Q1, 2022 Results on May 16, 2022

Else Nutrition Holdings Inc. Receives Formal Listing Approval for Its Novel

Price target decreased to CA$3.00

High number of new and inexperienced directors

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Releases the First-Ever U.S. Certified Baby Cereal - Safe of Heavy Metals

Else Nutrition Holdings Inc., Annual General Meeting, Jun 30, 2022

Else Nutrition Holdings Inc. Announces That Rouses Markets Has Added Two Additional Products Else Plant-Based Kids Shakes, in Chocolate and Vanilla Flavors